Sep 2026· Biochimica et biophysica acta. Reviews on cancer· pp.
189702
· 0 citations· 226 references
Medicine
TL;DR
A context-dependent state-transition model is proposed in which pressures are decoded by interconnected nutrient- and stress-sensing pathways, integrated through mitochondrial bioenergetic and redox adaptation, and translated by metabolite-dependent chromatin remodeling into persistent TAM functional programs that constrain the depth and durability of ICB responses.
Abstract
Immune checkpoint blockade (ICB) has transformed cancer therapy, but durable responses are frequently limited by tumor microenvironment-driven resistance. Tumor-associated macrophages (TAMs) are central mediators of this process because they sense metabolic stress and convert it into immunosuppressive programs that restrict antigen presentation, effector T cell entry, and cytotoxic function. This review conceptualizes the tumor microenvironment as a metabolic ecosystem shaped by hypoxia, lactate accumulation, acidosis, nutrient competition, lipid-rich niches, and amino-acid scarcity. We propose a context-dependent state-transition model in which these pressures are decoded by interconnected nutrient- and stress-sensing pathways, integrated through mitochondrial bioenergetic and redox adaptation, and translated by metabolite-dependent chromatin remodeling into persistent TAM functional programs that constrain the depth and durability of ICB responses. We further link glucose, lipid, and amino-acid metabolic circuitry to checkpoint resistance and propose therapeutic leverage tiers and biomarker layers for TAM metabolic reprogramming combined with ICB. This framework highlights actionable routes to overcome myeloid-driven immune resistance.
Tumor progression is driven by metabolic remodeling that generates a microenvironment characterized by nutrient deprivation, hypoxia, lactate accumulation, lipid dysregulation, and oxidative stress. These conditions affect innate immune populations, including natural killer (NK) cells, dendritic cells (DCs), macrophage...
J. Shin, Hye Yeon Choi, Jihyoung Kim et al.· Frontiers in Immunology· 0 citations
A narrative review critically examines the molecular crosstalk through which metabolic and ferroptosis-associated signals may shape macrophage inflammatory, immunoregulatory, tissue-remodeling, and oxidative-stress-associated programs, and discusses potential combinatorial strategies targeting this regulatory axis.
Hu-Chen Hu, Yue-Qi Ma· Journal of Cancer Metastasis...· 0 citations
The article further explores therapeutic strategies targeting metabolic nodes such as lactate dehydrogenase A, CD73/CD39 - adenosine axis, to reverse immunosuppression and enhance the efficacy of ICIs, and looks forward to the future direction of using "metabolism-immunity" typing to guide individualized combination th...
Gan-Yu Yi· International Journal of Bio...· 0 citations
Emerging evidence demonstrates that tumor metabolic reprogramming not only supports tumor-cell proliferation but also promotes the establishment of an immunosuppressive tumor microenvironment (TME) by altering nutrient competition and metabolite accumulation. Therefore, metabolic reprogramming and immune evasion should...
Hai-Lun Wang, Han-Yuan Zhao, Xue-Lu Pu et al.· Frontiers in Oncology· 0 citations
This comprehensive review elucidates how tumor-derived lactate systematically remodels the tumor microenvironment to facilitate distant dissemination and highlights the multi-targeted network pharmacology of Traditional Chinese Medicine formulations.
Tao Yang, Xin-Yu Yang, Yilin Gao et al.· Critical reviews in oncology...· 0 citations
Antigen-presenting cells (APCs) translate tumor-derived signals into adaptive immune responses, yet their function is shaped by the metabolically hostile tumor microenvironment (TME). Hypoxia, acidosis, nutrient scarcity, and immunoregulatory metabolite accumulation can reprogram myeloid APC metabolism, impair antigen...